Low-dose salinomycin induces anti-leukemic responses in AML and MLL

SUPPLEMENTARY MATERIALS AND METHODS
Apoptosis-based assays
Induction of apoptosis was assessed by measurement of caspase 3/7 activity or Annexin V staining. Caspase activity was evaluated using the Caspase-Glo® 3/7 luminescent assay system (Promega, Madison, WI, USA) as per the manufacturer's instructions for suspension cells. Membrane changes associated with the onset of programmed cell death were evaluated using an apoptosis detection kit (Annexin V-FITC protein, PI; eBioscience, Inc., San Diego, CA, USA), as per manufacturer's instructions, and subsequent measurement using a LSR II flow cytometer (BD Biosciences). Histogram plots were obtained and analyzed using Cyflogic software (CyFlo Ltd, Turku, Finland).
Western blot analysis
Total cell lysates were prepared after incubation of leukemic cells in media containing vehicle (0.01% DMSO) or salinomycin at the indicated dosage and time, using an SDS extraction protocol (Cell Signaling Technology, Danvers, MA, http://www.cellsignal.com). Proteins were separated by SDS-PAGE and probed with Atg7 (D12B11) and Beclin-1 (D40C5) at 1:1000 dilutions both from Cell Signaling. Protein loading was assessed using a mouse monoclonal β-actin primary antibody (1:5,000; Sigma-Aldrich, St Louis, MO). Blots were developed with a chemiluminescence detection system (Immobilon Western Chemiluminescent HRP Substrate; MerkMillipore, Billerica, MA), exposed to X-ray film (SLS/MOL 7016, Analab, Lisburn, U.K.) for up to 10
